Not yet recruitingNot applicableNCT06581991

Liquid Valine and Isoleucine in Maple Syrup Urine Disease

Studying Maple syrup urine disease

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Meta Healthcare Ltd
Principal Investigator: Anita MacDonald
Birmingham Children's Hospital, UK
Intervention: Valine oral solution (50mg/ml) and isoleucine oral solution (25mg/ml)(dietary_supplement)
Enrollment: 5 target
Eligibility: 16 years · All sexes
Timeline: 2024 – 2026

Collaborators

Birmingham Women's and Children's NHS Foundation Trust

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06581991 on ClinicalTrials.gov

← Back to all trials